Lahorewala Sarrah, Yin Zheng, Kinskey Jacob, Bobart Shane A, Edwards Angelina, Christensen Paul, Bertholf Roger L, Yi Xin
Department of Pathology and Immunology, Baylor College of Medicine, Baylor St. Luke's Medical Center, Houston, TX, United States.
Department of Radiology, Houston Methodist Hospital, Houston, TX, United States.
Clin Chem. 2025 Aug 1;71(8):870-883. doi: 10.1093/clinchem/hvaf071.
Accurate glomerular filtration rate (GFR) estimation is crucial for evaluating living kidney donors, especially when measured GFR (mGFR) is unavailable. This study compares the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI), full age spectrum (FAS), and European Kidney Function Consortium (EKFC) creatinine- and/or cystatin C-based estimated GFR (eGFR) equations against iohexol mGFR to determine the optimal equation for donor eligibility assessment in a US population.
1210 kidney donor candidates were retrospectively analyzed, comparing eGFR equations based on creatinine, cystatin C, or both against iohexol mGFR. Accuracy metrics (P10, P30, mean bias) and subgroup analyses for Black donors and age-based bias were evaluated. The classification performance of eGFR equations in donor eligibility was examined.
The 2021 CKD-EPIcr [AS (age, sex)] demonstrated the best accuracy across the overall cohort (P10 48.2%, P30 93.2%, mean bias -4.8 mL/min/1.73 m²). The 2021 CKD-EPIcr-cys (AS) excelled in Black donors (P10 60.3%, P30 95.4%, mean bias -3.6 mL/min/1.73 m²). Cystatin C-based equations showed higher negative bias, with the largest underestimation observed in older donors. All equations demonstrated <35% positive predictive value (PPV) for rejecting ineligible donors (<60 mL/min/1.73 m²) but >85% PPV in determining acceptable donors (≥90 mL/min/1.73 m²). Overall, 2021 CKD-EPIcr-cys (AS) was the most reliable for identifying acceptable donors (F1 score 83.9 at ≥90 mL/min/1.73 m²). Using age/sex-specific thresholds improved performance of all equations in donor eligibility classification compared to absolute thresholds.
No eGFR equation reliably rejected ineligible donors. 2021 CKD-EPIcr-cys (AS) exhibited the best overall performance for donor eligibility assessment.
准确估算肾小球滤过率(GFR)对于评估活体肾供体至关重要,尤其是在无法获得实测GFR(mGFR)时。本研究将慢性肾脏病流行病学协作组(CKD-EPI)、全年龄谱(FAS)和欧洲肾功能协会(EKFC)基于肌酐和/或胱抑素C的估算GFR(eGFR)方程与碘海醇mGFR进行比较,以确定在美国人群中用于供体资格评估的最佳方程。
对1210名肾供体候选人进行回顾性分析,将基于肌酐、胱抑素C或两者的eGFR方程与碘海醇mGFR进行比较。评估准确性指标(P10、P30、平均偏差)以及黑人供体和基于年龄的偏差的亚组分析。检查eGFR方程在供体资格方面的分类性能。
2021年CKD-EPIcr[AS(年龄、性别)]在整个队列中显示出最佳准确性(P10 48.2%,P30 93.2%,平均偏差-4.8 mL/min/1.73 m²)。2021年CKD-EPIcr-cys(AS)在黑人供体中表现出色(P10 60.3%,P30 95.4%,平均偏差-3.6 mL/min/1.73 m²)。基于胱抑素C的方程显示出更高的负偏差,在老年供体中观察到最大程度的低估。所有方程在拒绝不合格供体(<60 mL/min/1.73 m²)时的阳性预测值(PPV)均<35%,但在确定合格供体(≥90 mL/min/1.73 m²)时的PPV>85%。总体而言,2021年CKD-EPIcr-cys(AS)在识别合格供体方面最可靠(在≥90 mL/min/1.73 m²时F1分数为83.9)。与绝对阈值相比,使用年龄/性别特异性阈值可提高所有方程在供体资格分类中的性能。
没有eGFR方程能可靠地拒绝不合格供体。2021年CKD-EPIcr-cys(AS)在供体资格评估中表现出最佳的总体性能。